Evaluation of Patients With Blood Disorders
| Status: | Completed |
|---|---|
| Conditions: | Blood Cancer, Hematology |
| Therapuetic Areas: | Hematology, Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 4/5/2019 |
| Start Date: | April 21, 1998 |
| End Date: | August 23, 2017 |
Evaluation of Hematologic Patients - Training Protocol
The Hematology Service provides hematology consultations for patients at the Clinical Center
and participates in the training of hematology fellows. Patients with a broad range of
hematologic disorders must be available in order for the senior staff of the Service to
maintain clinical expertise and to provide the breadth of experience necessary for the
fellowship program. The purpose of this protocol is to meet these needs by allowing the
Hematology Service to see patients with a spectrum of hematologic diseases not studied on
existing research protocols at the NIH. These patients will be evaluated over the course of
several outpatient visits and returned to the care of their referring physicians.This study
was developed to evaluate and possibly treat patients with blood disorders. The Hematology
Service of the National Institutes of Health is responsible for the care of patients
participating in research studies. In addition the Hematology Service also provides
consultation for small groups of patients with blood disorders that have not been diagnosed
or that may need special testing.
This study will also provide doctors at the NIH the opportunity to learn more about a wide
range of blood disorders and conditions. Patients participating in this study will be
evaluated over the course of several outpatient visits and will continue to be cared for by
their regular physician.
and participates in the training of hematology fellows. Patients with a broad range of
hematologic disorders must be available in order for the senior staff of the Service to
maintain clinical expertise and to provide the breadth of experience necessary for the
fellowship program. The purpose of this protocol is to meet these needs by allowing the
Hematology Service to see patients with a spectrum of hematologic diseases not studied on
existing research protocols at the NIH. These patients will be evaluated over the course of
several outpatient visits and returned to the care of their referring physicians.This study
was developed to evaluate and possibly treat patients with blood disorders. The Hematology
Service of the National Institutes of Health is responsible for the care of patients
participating in research studies. In addition the Hematology Service also provides
consultation for small groups of patients with blood disorders that have not been diagnosed
or that may need special testing.
This study will also provide doctors at the NIH the opportunity to learn more about a wide
range of blood disorders and conditions. Patients participating in this study will be
evaluated over the course of several outpatient visits and will continue to be cared for by
their regular physician.
The Hematology Service provides hematology consultations for patients at the Clinical Center
and participates in the training of hematology fellows. Patients with a broad range of
hematologic disorders must be available in order for the senior staff of the Service to
maintain clinical expertise and to provide the breadth of experience necessary for the
fellowship program. The purpose of this protocol is to meet these needs by allowing the
Hematology Service to see patients with a spectrum of hematologic diseases not studied on
existing research protocols at the NIH. These patients will be evaluated over the course of
several outpatient visits and returned to the care of their referring physicians.
and participates in the training of hematology fellows. Patients with a broad range of
hematologic disorders must be available in order for the senior staff of the Service to
maintain clinical expertise and to provide the breadth of experience necessary for the
fellowship program. The purpose of this protocol is to meet these needs by allowing the
Hematology Service to see patients with a spectrum of hematologic diseases not studied on
existing research protocols at the NIH. These patients will be evaluated over the course of
several outpatient visits and returned to the care of their referring physicians.
- INCLUSION CRITERIA:
The patient must have or be suspected of having a blood disorder.
The patient must be clinically stable enough for outpatient evaluation.
The patients must be referred from a physician outside the NIH who will continue to provide
the patient's primary medical care.
EXCLUSION CRITERIA:
Inability of patient, parent or legal gaurdian to provide informed consent.
We found this trial at
1
site
9000 Rockville Pike
Bethesda, Maryland 20892
Bethesda, Maryland 20892
Phone: 800-411-1222
Click here to add this to my saved trials
